Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)

Palomino Laboratories (PALX) reported Total Liabilities of $336458.0 for Q4 2025, up 115.08% on a YoY basis from $156431.0 in Q4 2024, and down 66.32% sequentially from $999013.0 in Q3 2025.

Palomino Laboratories (PALX) Total Liabilities (2022 - 2025) Analysis & Trends

Palomino Laboratories (PALX) has 4 years of Total Liabilities data on file, last reported at $336458.0 in Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 115.08% year-over-year to $336458.0; the trailing twelve-month figure through Dec 2025 stood at $336458.0 (up 115.08% YoY), and the FY2025 full-year result was $336458.0, up 115.08% from the prior year.
  • Total Liabilities declined to $336458.0 in Q4 2025, from $999013.0 in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $27804.0 in Q4 2022.
  • A 4-year average of $271921.0 and a median of $194658.0 in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities soared 40.14% in 2024 and jumped 350.51% in 2025, its largest moves.
  • Tracing PALX's Total Liabilities over 4 years: stood at $27804.0 in 2022, then jumped by 301.46% to $111621.0 in 2023, then surged by 40.14% to $156431.0 in 2024, then soared by 115.08% to $336458.0 in 2025.
  • Business Quant data shows PALX's Total Liabilities at $336458.0 in Q4 2025, $999013.0 in Q3 2025, and $364431.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 156,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Dec 31, 2022 27,804.00